Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Douglas

Showing results (101-110 of 1,125) with videos related to

Pageof 113
Sort By:
Bioinformatics (Oxford, England)|March 7, 2008
PedMine--a simulated annealing algorithm to identify maximally unrelated individuals in population isolatesJulie A Douglas, Conner I Sandefur
Current Bioactive Compounds|October 16, 2009
BIOLOGICALLY ACTIVE NATURAL PRODUCTS OF THE GENUS CALLICARPAWilliam P Jones, A Douglas Kinghorn
British Journal of Pharmacology|September 1, 1990
Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the ratS A Douglas, C R Hiley
Physical Review Letters|September 26, 2012
General linewidth formula for steady-state multimode lasing in arbitrary cavitiesY D Chong, A Douglas Stone
Preventive Medicine|October 9, 2020
COVID-19 treatment resource disparities and social disadvantage in New York CityJason A Douglas, Andrew M Subica
Journal of Protein Chemistry|February 1, 1996
Computational sequence analysis of matrix metalloproteinasesQ A Sang, D A Douglas
Plos One|April 30, 2013
A method to prioritize quantitative traits and individuals for sequencing in family-based studiesKaanan P Shah, Julie A Douglas
Respiratory Care|September 9, 2000
Left hemithorax opacification in a term newborn infantK A Douglas, B S Bradley
Trends in Cardiovascular Medicine|April 3, 2001
Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular diseaseS A Douglas, E H Ohlstein
Clinical and Experimental Immunology|October 1, 1982
C-peptide antibodies induced by bovine insulin therapyW G Reeves, C A Douglas
Pageof 113

Showing results (101-110 of 1,125) with videos related to

Sort By:
Pageof 113
Bioinformatics (Oxford, England)|March 7, 2008
PedMine--a simulated annealing algorithm to identify maximally unrelated individuals in population isolatesJulie A Douglas, Conner I Sandefur
Current Bioactive Compounds|October 16, 2009
BIOLOGICALLY ACTIVE NATURAL PRODUCTS OF THE GENUS CALLICARPAWilliam P Jones, A Douglas Kinghorn
British Journal of Pharmacology|September 1, 1990
Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the ratS A Douglas, C R Hiley
Physical Review Letters|September 26, 2012
General linewidth formula for steady-state multimode lasing in arbitrary cavitiesY D Chong, A Douglas Stone
Preventive Medicine|October 9, 2020
COVID-19 treatment resource disparities and social disadvantage in New York CityJason A Douglas, Andrew M Subica
Journal of Protein Chemistry|February 1, 1996
Computational sequence analysis of matrix metalloproteinasesQ A Sang, D A Douglas
Plos One|April 30, 2013
A method to prioritize quantitative traits and individuals for sequencing in family-based studiesKaanan P Shah, Julie A Douglas
Respiratory Care|September 9, 2000
Left hemithorax opacification in a term newborn infantK A Douglas, B S Bradley
Trends in Cardiovascular Medicine|April 3, 2001
Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular diseaseS A Douglas, E H Ohlstein
Clinical and Experimental Immunology|October 1, 1982
C-peptide antibodies induced by bovine insulin therapyW G Reeves, C A Douglas
Pageof 113